57 filings
8-K
HOOK
Hookipa Pharma Inc
9 May 24
Results of Operations and Financial Condition
7:03am
8-K
HOOK
Hookipa Pharma Inc
25 Apr 24
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
7:10am
8-K
HOOK
Hookipa Pharma Inc
22 Mar 24
Results of Operations and Financial Condition
7:08am
8-K
HOOK
Hookipa Pharma Inc
31 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
HOOK
Hookipa Pharma Inc
29 Jan 24
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
8:12am
8-K
845 6f30wkf
21 Dec 23
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
7:06am
8-K
7rqg6kqq7wlgh4 ftr
1 Dec 23
Departure of Directors or Certain Officers
4:46pm
8-K
jrlgs223xmtq37h
9 Nov 23
Results of Operations and Financial Condition
7:05am
8-K
kcnanhbp
20 Oct 23
Departure of Directors or Certain Officers
4:05pm
8-K
zdlaqp5u2crgg bor
13 Sep 23
HOOKIPA announces executive leadership change
8:47am
8-K
00fllg3wruur9yqi22
10 Aug 23
Results of Operations and Financial Condition
7:05am
8-K
ojks7hq sovy5cnep5
4 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
3zh 7q0uw8t5vwh3e
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
ipia57tl
1 Jun 23
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
7:37pm
8-K
dh8q 33urd42a4zi
31 May 23
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
5:24pm
8-K
8z7xkg89k1gen4wl0
11 May 23
Results of Operations and Financial Condition
7:03am
8-K
9t5wsqbm r6f
13 Apr 23
Departure of Directors or Certain Officers
4:03pm
8-K
uftyas2o
15 Mar 23
Results of Operations and Financial Condition
7:01am
8-K
5e2pfn amxi
13 Mar 23
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
4:22pm
8-K
qpzecoa
20 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm